Browsing Tag
United States
338 posts
Why Thermo Fisher Scientific (NASDAQ: TMO) is spending US$9.4bn on Clario to dominate clinical-trial analytics
Find out how Thermo Fisher’s US$9.4 billion acquisition of Clario is reshaping the clinical-trial services industry and what it means for investors.
How Nvidia became the first $5 trillion company—and what it means for AI, investors, and global tech power plays
Discover how Nvidia just hit a historic $5 trillion valuation and what it means for the AI surge, investors and global tech markets—read more now!
Will orforglipron turn Eli Lilly into the king of GLP-1s? The FDA decision that could change obesity care
Eli Lilly is stockpiling orforglipron pills ahead of FDA approval. Explore the risks, rewards, and why investors are paying close attention to this launch.
Why Xtreme One bought Borroka Promotions—And what it means for fight fans and investors
Xtreme One Entertainment expands into Las Vegas with Borroka Promotions acquisition. Find out what this means for MMA, investors, and the future of XONI.
Why the U.S. just bet $80bn on nuclear energy—And why Westinghouse and Cameco are at the center
The U.S. teams up with Westinghouse, Cameco and Brookfield to revive its nuclear reactor build-out with $80B in commitments. Find out what it means.
Apple or Microsoft — Who wins the $4tn race that could redefine Big Tech power?
Apple and Microsoft near $4 trillion market caps. Discover what drives this milestone, how AI and cloud shape valuations, and what investors should watch next.
Inside Amazon’s 30,000-job layoff plan: How AI, automation, and cost discipline are redefining the company
Find out why Amazon is laying off 30,000 corporate employees, how AI is driving the shift, and what this means for its stock and future growth.
Casa Mamita and Giant taco dinner kits recalled after allergen mix-up involving milk-based cocoa powder
Teasdale Latin Foods recalls select taco dinner kits sold across major U.S. retailers due to undeclared milk. See affected products and what consumers should do.
This ear-worn device just got FDA clearance to treat kids’ gut pain—What NeurAxis did right
NeurAxis gains FDA clearance for IB-Stim in treating pediatric gut disorders. Find out what this means for investors and the medtech market now.
Is Ampa’s $8.5m raise the breakthrough moment for portable TMS in U.S. mental health care?
Ampa raises $8.5M to launch its FDA-cleared, portable TMS device for depression treatment across U.S. clinics. Can it reshape mental health delivery?